International Flavors & Fragrances Inc. (IFF) Stock Analysis
IFF is converting a complex DuPont-era conglomerate into a defensible specialty-ingredients pure play, with deleveraging, buybacks, margin recovery, and multiple expansion supporting attractive five-year upside despite execution and antitrust risks.
Overview
IFF is a critical B2B supplier of taste, scent, and biological ingredients to global CPG, personal-care, fragrance, and nutrition customers. Its formulations often represent only 1%–5% of a customer’s COGS but determine 100% of brand identity, creating high switching costs and durable relationships. Management is transforming the post-2021 DuPont merger structure by selling Pharma Solutions for up to $2.85 billion, completing the SCL disposal, pursuing a $75 million botanical-extracts sale, and targeting a mid-2027 close for the $4.3 billion Food Ingredients divestiture. **Q2 2026 continuing-operations sales were $1.954 billion, up 6% currency-neutral, and adjusted EBITDA was $408 million at a 20.9% margin.** FY2026 guidance calls for $7.4 billion–$7.6 billion of sales and $1.53 billion–$1.60 billion of EBITDA. The report views IFF as undervalued at 14.6x EV/EBITDA versus Givaudan at 20.6x, with catalysts including $3.8 billion of net proceeds, debt reduction, $2.5 billion of buybacks, stranded-cost removal, and potential multiple expansion.